Centene(US:CNC) Prnewswireยท2025-07-25 10:00Financial Performance - Centene Corporation reported total revenues of $48.742 billion for Q2 2025, an increase of 22% from $39.836 billion in Q2 2024 [1] - Premium and service revenues rose 18% to $42.467 billion compared to $35.973 billion in the same period last year [6] - The company experienced a diluted loss per share of $(0.51) for Q2 2025, compared to earnings of $2.16 per share in Q2 2024 [18][29] - Adjusted diluted loss per share was $(0.16) for Q2 2025, down from $2.42 in Q2 2024 [18] Membership Trends - Total at-risk membership as of June 30, 2025, was 28,004,900, an increase from 25,709,600 in 2024 [3] - Traditional Medicaid membership decreased to 11,227,400 from 11,640,900 year-over-year [3] - Marketplace membership increased significantly to 5,862,800 from 4,401,300 in the previous year [3] Cost and Expense Management - The health benefits ratio (HBR) for Q2 2025 was 93.0%, up from 87.6% in Q2 2024, primarily due to increased medical costs [1][12] - Selling, general and administrative (SG&A) expense ratio was 7.1% for Q2 2025, down from 8.0% in Q2 2024, reflecting better expense management [1][12] Cash Flow and Balance Sheet - Cash flow from operations for Q2 2025 was $1.785 billion, driven by improved pharmacy rebate remittance timing [1][12] - As of June 30, 2025, the company had cash, investments, and restricted deposits totaling $37.5 billion, with total debt at $17.6 billion [8][27] Community Engagement and Recognition - Centene has been actively involved in community support, including relief efforts for tornado-affected areas [4] - The company was recognized as one of Newsweek's America's Greatest Workplaces for the third consecutive year [4]